Inhibikase Therapeutics, Inc. SEC filings IKT
Inhibikase Therapeutics, Inc. has 368 filings in SEC EDGAR's recent list, going back to Aug 31, 2018. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 20, 2026 (officer or director change, regulation fd disclosure). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Oct 20, 2026 | Oct 19, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 8, 2026 | Sep 8, 2026 |
| 8-K |
Current report
Auditor change
|
Aug 26, 2026 | Aug 21, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Jul 29, 2026 | Jul 29, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Jul 23, 2026 | Jul 23, 2026 |
| 8-K |
Current report
Other events
|
Jul 14, 2026 | Jul 14, 2026 |
| 8-K |
Current report
Officer or director change, Bylaw or fiscal year change, Shareholder vote results
|
Jun 29, 2026 | Jun 26, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 7, 2026 | Apr 7, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 26, 2026 | Mar 26, 2026 |
| 8-K |
Current report
Other events
|
Dec 19, 2025 | Dec 19, 2025 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 21, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Other events
|
Nov 20, 2025 | Nov 20, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 14, 2025 | Nov 14, 2025 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Aug 14, 2025 | Aug 14, 2025 |
| 8-K |
Current report
Shareholder vote results
|
Jun 30, 2025 | Jun 27, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 14, 2025 | Apr 11, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure
|
Feb 24, 2025 | Feb 21, 2025 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Feb 18, 2025 | Feb 13, 2025 |
| 8-K |
Current report
Other events
|
Jan 29, 2025 | Jan 29, 2025 |
| 8-K |
Current report
Bylaw or fiscal year change, Shareholder vote results
|
Jan 6, 2025 | Jan 3, 2025 |
| 8-K |
Current report
Agreement ended
|
Dec 5, 2024 | Dec 2, 2024 |
| 8-K |
Current report
Material agreement, Officer or director change, Regulation FD disclosure
|
Oct 22, 2024 | Oct 21, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Officer or director change, Regulation FD disclosure, Other events
|
Oct 10, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 9, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Aug 6, 2024 | Aug 5, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 10, 2024 | Jun 7, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
May 20, 2024 | May 20, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Apr 30, 2024 | Apr 26, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 19, 2024 | Apr 18, 2024 |
| 8-K/A |
Amended current report
Officer or director change
|
Apr 2, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Other events
|
Feb 7, 2024 | Feb 7, 2024 |
| 8-K |
Current report
Material agreement
|
Feb 1, 2024 | Feb 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 16, 2024 | Jan 16, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 20, 2023 | Sep 20, 2023 |
| 8-K |
Current report
Other events
|
Jul 17, 2023 | Jul 17, 2023 |
| 8-K |
Current report
Change to shareholder rights, Bylaw or fiscal year change, Regulation FD disclosure
|
Jun 29, 2023 | Jun 28, 2023 |
| 8-K |
Current report
Shareholder vote results
|
Jun 28, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 22, 2023 | Mar 22, 2023 |
| 8-K |
Current report
Other events
|
Mar 13, 2023 | Mar 13, 2023 |
| 8-K |
Current report
Officer or director change
|
Mar 6, 2023 | Mar 1, 2023 |
| 8-K |
Current report
Material agreement, Agreement ended, Unregistered share sale, Regulation FD disclosure
|
Jan 26, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Other events
|
Jan 25, 2023 | Jan 25, 2023 |
| 8-K |
Current report
Listing notice
|
Jan 24, 2023 | Jan 24, 2023 |
| 8-K |
Current report
Results of operations
|
Nov 17, 2022 | Nov 14, 2022 |
| 8-K |
Current report
Other events
|
Nov 7, 2022 | Nov 7, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Sep 16, 2022 | Sep 16, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Sep 1, 2022 | Sep 1, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 15, 2022 | Aug 15, 2022 |
| 8-K |
Current report
Listing notice
|
Jul 29, 2022 | Jul 25, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2022 | Jun 24, 2022 |
| 8-K |
Current report
Material agreement
|
May 17, 2022 | May 16, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Apr 21, 2022 | Apr 21, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 24, 2022 | Mar 18, 2022 |
| 8-K/A |
Amended current report
Officer or director change
|
Mar 21, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Officer or director change
|
Mar 8, 2022 | Mar 3, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 20, 2022 | Jan 20, 2022 |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 19, 2021 | Oct 19, 2021 |
| 8-K |
Current report
Other events
|
Sep 8, 2021 | Sep 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Aug 17, 2021 | Aug 17, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 29, 2021 | Jun 25, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 21, 2021 | Jun 18, 2021 |
| 8-K |
Current report
Material agreement
|
Jun 16, 2021 | Jun 15, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 1, 2021 | Jun 1, 2021 |
| 8-K |
Current report
Results of operations
|
Apr 1, 2021 | Apr 1, 2021 |
| 8-K |
Current report
Regulation FD disclosure
|
Feb 8, 2021 | Feb 7, 2021 |
| 8-K |
Current report
Unregistered share sale, Bylaw or fiscal year change, Other events
|
Dec 29, 2020 | Dec 22, 2020 |
Showing 70 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- IKT (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Wilmington, DE
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1750149
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.